Home › Therapeutic areas › GI/Hepatology › Primary Sclerosing Cholangitis
Primary Sclerosing Cholangitis (1 companies)
Companies with an active program in Primary Sclerosing Cholangitis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| CMMB | Chemomab Therapeutics | GI/HepatologyImmunology+1 Rare | 1 | Phase 2 | $10.6M | 4 |
No companies match.